Treatment decisions should be made in consultation with a licensed medical professional who can evaluate individual health factors, contraindications, and clinical eligibility
Obscured Sourcing: Advertising drug products branded with the telehealth firms own name or trademark without clarifying that the firm is not the actual compounder
compounded oral forms (and any oral tirzepatide) lack FDA review for pharmacokinetics, potency, and efficacy
Unsurprisingly, this led to increased coverage for Wegovy, and the coverage landscape is likely to change again with the expected approval in this indication for key competitor Zepbound
Many patients notice mild digestive symptoms such as bloating, gas, or loose stools, especially after fatty meals